Naltrexon


Program och inbjudan

The Swedish Carnegie Institute and the Clinic for Dependency Disorders, University Hospital, Linköping, welcome you to a seminar (39:th Carnegie Seminar) with world leading experts in the field of naltrexone treatment:
Long acting naltrexone in the treatment of opiate dependence – is the time ripe for an introduction in Sweden?

At present the treatment of opiate dependence in Sweden is dominated by maintenance treatment with methadone and buprenorphine, which has been a great step forward in the rehabilitation of even heavily dependent heroin users. There are, however, users who don’t want maintenance treatment or who do not qualify for it. There are also well rehabilitated users with methadone or buprenorphine who wish to quit but don’t dare for fear of relapse in heroin use. The use of antagonist treatment in opiate addiction has been problematic, mainly because of the problem of compliance. The emergence of long acting preparations of naltrexone may present new hope for this treatment to find its place in the arsenal of treatment options.

Time: Wednesday May 21, 2008
Place: The Swedish Society of Medicine, Klara Östra Kyrkogata 10, Stockholm

Preliminary schedule:

8:30 Registration and coffee

9:00 Agonism or antagonism treatments for substance use disorders?
Bo Söderpalm, M.D., Ph.D. Sahlgrenska Academy and the Clinic for Dependency Disorders, Sahlgrenska University Hospital

9:30 Odysseus at the mast. On the treatment model and the choices in Norwegian research program
Helge Waal, Professor, Head of Norwegian Centre for Addiction Research, University of Oslo.

10:00 Studies investigating the safety and clinical efficacy of the Australian sustained release naltrexone implant
Gary Hulse, Professor of Addiction Medicine,University of Western Australia

11:00 Coffee/Tea

11:15 Results from a RCT (Randomly Controlled Trial) comparing long acting naltrexone implant with methadone maintenance treatment in connection with release from prison
Philipp Lobmaier, Research fellow, Norwegian Centre for Addiction Research, University of Oslo.

12:00 Lunch (individually at external restaurants)

13:30 Results from a RCT comparing “usual care” and “usual care in combination with long acting naltrexone implant in detoxified heroin addicts”
Nikolaj Kunoe, Research fellow, Norwegian Centre for Addiction Research, University of Oslo.

14:15-16:00 Open discussion

The seminar will be held mainly in English. Participation in the seminar is free of charge. For participation mail to staff@carnegieinst.se before May, 12, 2008. Please mark your application with Naltrexon seminar. The number of seats is limited. For more information contact: Kerstin Käll, kerstin.kall@lio.se

Kerstin Käll
M.D., PhD Clinic for Dependency Disorders,
University Hospital, Linköping

Peder Langenskiöld
Executive Director
Swedish Carnegie Institute